(Q36946317)

17 August 2017

1 reference

title

Hepatitis C virus entry (English)

1 reference

17 August 2017

1 reference

1 reference

2

Charles M Rice

1 reference

17 August 2017

Thomas von Hahn

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

19 September 2007

1 reference

Journal of Biological Chemistry

17 August 2017

published in

1 reference

17 August 2017

volume

283

1 reference

17 August 2017

issue

7

1 reference

17 August 2017

page(s)

3689-3693

1 reference

Global epidemiology of hepatitis C virus infection

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Challenges and successes in developing new therapies for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

From structure to function: new insights into hepatitis C virus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Specific detection of minus-strand hepatitis C virus RNA by reverse-transcription polymerase chain reaction on PolyA(+)-purified RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Binding of hepatitis C virus to CD81

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Characterization of functional hepatitis C virus envelope glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

In vitro veritas? The challenges of studying hepatitis C virus infectivity in a test tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

The tetraspanin web modulates immune-signalling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

The molecular players of sperm-egg fusion in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

The Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Diverse CD81 Proteins Support Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

CD81 is an entry coreceptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Human Serum Amyloid A Protein Inhibits Hepatitis C Virus Entry into Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Claudins in occluding junctions of humans and flies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Effect of Cell Polarization on Hepatitis C Virus Entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Effect of estrogen on scavenger receptor BI expression in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Junction adhesion molecule is a receptor for reovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

Characterization of truncated forms of hepatitis C virus glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.R700024200

21 January 2018

Identifiers

DOI

10.1074/JBC.R700024200

1 reference

17 August 2017

1 reference